Absher Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
11,574
-225
-2% -$26.3K 0.17% 38
2026
Q1
$1.42M Sell
11,799
-73
-0.6% -$8.43K 0.17% 40
2025
Q4
$1.25M Buy
11,872
+753
+7% +$70.7K 0.15% 41
2025
Q3
$933K Buy
11,119
+1,769
+19% +$146K 0.11% 47
2025
Q2
$740K Buy
9,350
+468
+5% +$37.2K 0.09% 47
2025
Q1
$797K Buy
8,882
+653
+8% +$61K 0.1% 44
2024
Q4
$819K Buy
8,229
+1,248
+18% +$129K 0.11% 45
2024
Q3
$793K Buy
6,981
+1,045
+18% +$124K 0.1% 44
2024
Q2
$735K Sell
5,936
-430
-7% -$55.4K 0.1% 43
2024
Q1
$840K Buy
6,366
+9
+0.1% +$1.11K 0.12% 39
2023
Q4
$693K Buy
6,357
+96
+2% +$9.96K 0.1% 40
2023
Q3
$645K Buy
6,261
+1,037
+20% +$112K 0.11% 41
2023
Q2
$603K Sell
5,224
-111
-2% -$12.6K 0.1% 41
2023
Q1
$568K Sell
5,335
-378
-7% -$40.8K 0.1% 40
2022
Q4
$634K Sell
5,713
-377
-6% -$38.5K 0.12% 40
2022
Q3
$524K Sell
6,090
-496
-8% -$44.3K 0.11% 41
2022
Q2
$600K Sell
6,586
-7,123
-52% -$631K 0.12% 41
2022
Q1
$1.13M Buy
13,709
+282
+2% +$22.2K 0.19% 35
2021
Q4
$1.03M Buy
13,427
+695
+5% +$55.4K 0.17% 37
2021
Q3
$956K Buy
12,732
+2,542
+25% +$193K 0.18% 37
2021
Q2
$792K Buy
10,190
+1,071
+12% +$79.7K 0.14% 41
2021
Q1
$671K Sell
9,119
-1,488
-14% -$110K 0.13% 41
2020
Q4
$828K Buy
10,607
+118
+1% +$9.03K 0.17% 38
2020
Q3
$830K Sell
10,489
-435
-4% -$34.1K 0.2% 37
2020
Q2
$806K Buy
10,924
+224
+2% +$16.9K 0.21% 35
2020
Q1
$786K Buy
10,700
+1,055
+11% +$82.9K 0.24% 33
2019
Q4
$794K Buy
+9,645
New +$792K 0.2% 36

Other funds holding MRK

Absher Wealth Management's MRK Position: Q2 2026 in Review

Absher Wealth Management reduced its Merck (MRK) stake by 1.9% in Q2 2026, selling an estimated $26.3K and leaving 11,574 shares worth $1.49M. The position accounts for 0.17% of the portfolio, ranked #38.

Absher Wealth Management first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Absher Wealth Management held 11,574 shares of Merck worth $1.49M as of Q2 2026.
  • Absher Wealth Management sold 225 Merck shares in Q2 2026, an estimated $26.3K.
  • Merck made up 0.17% of Absher Wealth Management's portfolio in Q2 2026, its #38 holding.
  • Absher Wealth Management first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Absher Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.